Per Norlén

Vorstandsvorsitzender bei WNTRESEARCH AB

Vermögen: - $ am 30.04.2024

54 Jahre

Health Technology

Commercial Services

Consumer Services

Aktive Positionen von Per Norlén

Unternehmen	Position	Beginn	Ende
WNTRESEARCH AB	Vorstandsvorsitzender	10.01.2024	-
University of Lund	Corporate Officer/Principal	-	-
Atlas Therapeutics AB Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
EVAXION BIOTECH A/S	Vorstandsvorsitzender	03.10.2022	29.08.2023
EVAXION BIOTECH A/S	Technik-/Wissenschafts-/F&E-Leiter	01.03.2023	29.08.2023
Targinta AB Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.	Vorstandsvorsitzender	01.09.2021	01.09.2022
XINTELA AB	Technik-/Wissenschafts-/F&E-Leiter	01.07.2021	01.09.2022
ALLIGATOR BIOSCIENCE AB	Vorstandsvorsitzender	01.07.2015	18.03.2021
ALLIGATOR BIOSCIENCE AB	Technik-/Wissenschafts-/F&E-Leiter	01.09.2010	01.01.2018
A Bioscience Incentive AB	Direktor/Vorstandsmitglied	-	-
A Bioscience Incentive AB	Vorsitzender	-	-
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Corporate Officer/Principal	-	-

University of Lund

Doctorate Degree

International

Schweden	9
Dänemark	2

Operativ

Chief Executive Officer	4
Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
ALLIGATOR BIOSCIENCE AB	Health Technology
EVAXION BIOTECH A/S	Health Technology
XINTELA AB	Health Technology
WNTRESEARCH AB	Health Technology

Private Unternehmen	4
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Commercial Services
Atlas Therapeutics AB Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.	Health Technology
A Bioscience Incentive AB
Targinta AB Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022.	Health Technology